Bethany Dhondt
Family Medicine · Humansville, MONPI 1356782619
Payments from drug & device makers
Across 269 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$545
- AbbVie$414
- AstraZeneca$395
- Alkermes, Inc.$394
- Lundbeck LLC$371
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$331
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,656100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,660 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 40 | $80,372 |
| OzempicSemaglutide | 66 | $74,077 |
| EliquisApixaban | 71 | $62,136 |
| RybelsusSemaglutide | 44 | $61,212 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 60 | $42,724 |
| TrulicityDulaglutide | 31 | $41,235 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $27,132 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $24,468 |
| OxycontinOxycodone Hcl | 15 | $23,916 |
| XareltoRivaroxaban | 39 | $23,875 |
| FarxigaDapagliflozin Propanediol | 17 | $20,264 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 31 | $18,250 |
| ByettaExenatide | 17 | $17,874 |
| LinzessLinaclotide | 21 | $16,590 |
| Novolog FlexpenInsulin Aspart | 44 | $14,937 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $545 | $135,289110 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Byetta, Symbicort | $395 | $93,021129 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $248 | $80,37240 claims |
| PfizerEliquis | $43 | $62,13671 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $209 | $54,52644 claims |
| AbbVieLinzess, Restasis, Creon | $414 | $31,99353 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $104 | $31,49038 claims |
| Astellas Pharma US IncMyrbetriq | $102 | $9,93122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Humansville
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.